Primary Care Clinics in Avon, OH Accepting Medicare
8 Primary Care Clinics found. Showing 1 - 8
 Minanti Health Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 35734 Bentley Dr, Avon, OH 44011 Phone: 440-226-5026 |
Vox Solutions, Llc General Practice Medicare: Not Enrolled in Medicare Practice Location: 4219 Queens Gate, Avon, OH 44011 Phone: 330-347-5647 |
Uh Conneaut Medical Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1480 Center Rd Ste A, Avon, OH 44011 Phone: 440-695-6550 Fax: 216-201-6915 |
Community Family Care Inc Family Medicine Medicare: Medicare Enrolled Practice Location: 2217 Wisteria Way, Avon, OH 44011 Phone: 440-934-7080 Fax: 440-934-0810 |
Healthspan Integrated Care Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1426 Center Rd, Avon, OH 44011 Phone: 216-265-8810 Fax: 216-265-8890 |
Avon Medical Offices Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1426 Center Road, Avon, OH 44011 Phone: 216-265-8844 Fax: 216-265-8890 |
Corporation Internal Medicine Medicare: Medicare Enrolled Practice Location: 36465 Detroit Rd, Avon, OH 44011 Phone: 440-934-5236 |
Pyramed Healthcare Group, Ltd Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1480 Center Rd, Suite A, Avon, OH 44011 Phone: 440-937-4600 Fax: 440-365-5486 |
News Archive
New study identifies best practices to improve breastfeeding in African American community
An abundance of data underscore the importance of breastfeeding and human milk for the optimal health of infants, children, mothers, and society.
Software tool can predict how drugs can be combined to create effective treatments
With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs-including unlikely candidates-can be combined in new ways to create more effective treatments.
Ceram-lead project to develop new biomaterials and new arterial stents awarded Euro 5.874M by the European Union
As co-ordinator of the European project ‘ReBioStent', Ceram, the international materials technology company, is pleased to announce that the project, to develop new biomaterials and new arterial stents, has been awarded Euro 5.874M by the European Union.
CardioExcyte 96 for cardiac toxicity profiling and screening introduced by Nanion
Cardiac safety assessment is a vital part of drug development since late withdrawals of compound candidates, due to heart liability issues such as ventricular arrhythmia, are very costly. In-vivo methods give highly relevant information but are extremely low throughput allowing the analysis of only a handful of compounds.
› Verified 4 days ago